Takemura Yusuke, Shinoda Masahiro, Hasegawa Yasushi, Yamada Yohei, Obara Hideaki, Kitago Minoru, Kasahara Mureo, Umeshita Koji, Eguchi Susumu, Kitagawa Yuko, Ohdan Hideki, Egawa Hiroto
Department of Surgery Keio University School of Medicine Tokyo Japan.
Digestive Disease Center Mita Hospital, International University of Health and Welfare Tokyo Japan.
Ann Gastroenterol Surg. 2023 Feb 9;7(4):654-665. doi: 10.1002/ags3.12661. eCollection 2023 Jul.
Liver allografts from brain-dead donors, which were declined and were eventually not transplanted due to accompanying marginal factors, have never been surveyed in Japan. We surveyed the declined allografts and discussed the graft potential focusing on various marginal factors.
We collected data on brain-dead donors between 1999 and 2019 from the Japan Organ Transplant Network. We divided their liver allografts into declined (nontransplanted) and transplanted ones, and then characterized declined ones focusing on their timepoints of decline and accompanying marginal factors. For each marginal factor, we calculated the decline rate from the number of declined and transplanted allografts, and assessed the 1-year graft survival rate from transplanted allografts.
A total of 571 liver allografts were divided into 84 (14.7%) declined and 487 (85.3%) transplanted ones. In the declined allografts, a majority was declined after laparotomy ( = 55, 65.5%), most of which had steatosis and/or fibrosis ( = 52). Out of the moderate steatotic (without ≥ 2 fibrosis) allografts ( = 33), 21 were declined and 12 were transplanted, leading to a 63.6% decline rate. The latter 12 achieved a 92.9% 1-year graft survival rate after transplantation. Comparison of donor background showed no significant difference between the declined and transplanted allografts.
Pathological abnormalities of steatosis/fibrosis seem to be the most common donor factor leading to graft decline in Japan. Allografts with moderate steatosis were highly declined; however, transplanted ones achieved promising outcomes. This national survey highlights the potential utility of liver allografts with moderate steatosis.
在日本,因伴有边缘因素而被拒绝且最终未进行移植的脑死亡供体肝脏移植物从未被调查过。我们对被拒绝的移植物进行了调查,并围绕各种边缘因素讨论了移植物的潜力。
我们从日本器官移植网络收集了1999年至2019年间脑死亡供体的数据。我们将他们的肝脏移植物分为被拒绝(未移植)和已移植的两类,然后重点根据拒绝时间点和伴随的边缘因素对被拒绝的移植物进行特征描述。对于每个边缘因素,我们根据被拒绝和已移植移植物的数量计算拒绝率,并评估已移植移植物的1年移植物存活率。
总共571例肝脏移植物被分为84例(14.7%)被拒绝和487例(85.3%)已移植的。在被拒绝的移植物中,大多数是在剖腹术后被拒绝的(n = 55,65.5%),其中大多数有脂肪变性和/或纤维化(n = 52)。在中度脂肪变性(无≥2级纤维化)的移植物(n = 33)中,21例被拒绝,12例被移植,导致拒绝率为63.6%。后12例移植后1年移植物存活率达到92.9%。供体背景比较显示,被拒绝和已移植的移植物之间无显著差异。
脂肪变性/纤维化的病理异常似乎是日本导致移植物被拒绝的最常见供体因素。中度脂肪变性的移植物被高度拒绝;然而,已移植的移植物取得了良好的结果。这项全国性调查突出了中度脂肪变性肝脏移植物的潜在效用。